376 related articles for article (PubMed ID: 30009488)
21. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Lattanzi L; Rozera C; Marescotti D; D'Agostino G; Santodonato L; Cellini S; Belardelli F; Gavioli R; Ferrantini M
Immunobiology; 2011 May; 216(5):537-47. PubMed ID: 21093097
[TBL] [Abstract][Full Text] [Related]
22. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.
Szmania S; Galloway A; Bruorton M; Musk P; Aubert G; Arthur A; Pyle H; Hensel N; Ta N; Lamb L; Dodi T; Madrigal A; Barrett J; Henslee-Downey J; van Rhee F
Blood; 2001 Aug; 98(3):505-12. PubMed ID: 11468143
[TBL] [Abstract][Full Text] [Related]
23. Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma.
Liu H; Chen L; Liu J; Meng H; Zhang R; Ma L; Wu L; Yu S; Shi F; Li Y; Zhang L; Wang L; Feng S; Zhang Q; Peng Y; Wu Q; Liu C; Chang X; Yang L; Uemura Y; Yu X; Liu T
Cancer Lett; 2017 Dec; 411():182-190. PubMed ID: 28947140
[TBL] [Abstract][Full Text] [Related]
24. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.
Arrode G; Boccaccio C; Lulé J; Allart S; Moinard N; Abastado JP; Alam A; Davrinche C
J Virol; 2000 Nov; 74(21):10018-24. PubMed ID: 11024130
[TBL] [Abstract][Full Text] [Related]
25. Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Willemen Y; Van den Bergh JM; Lion E; Anguille S; Roelandts VA; Van Acker HH; Heynderickx SD; Stein BM; Peeters M; Figdor CG; Van Tendeloo VF; de Vries IJ; Adema GJ; Berneman ZN; Smits EL
Cancer Immunol Immunother; 2015 Jul; 64(7):831-42. PubMed ID: 25863943
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY
Front Immunol; 2018; 9():727. PubMed ID: 29910795
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.
Carbonneil C; Aouba A; Burgard M; Cardinaud S; Rouzioux C; Langlade-Demoyen P; Weiss L
AIDS; 2003 Aug; 17(12):1731-40. PubMed ID: 12891059
[TBL] [Abstract][Full Text] [Related]
28. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.
Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M
J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489
[TBL] [Abstract][Full Text] [Related]
29. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
Hasan AN; Kollen WJ; Trivedi D; Selvakumar A; Dupont B; Sadelain M; O'Reilly RJ
J Immunol; 2009 Aug; 183(4):2837-50. PubMed ID: 19635907
[TBL] [Abstract][Full Text] [Related]
30. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.
Leplina OY; Tyrinova TV; Tikhonova MA; Ostanin AA; Chernykh ER
Cytokine; 2015 Jan; 71(1):1-7. PubMed ID: 25174880
[TBL] [Abstract][Full Text] [Related]
31. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
[TBL] [Abstract][Full Text] [Related]
32. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
33. Improved Function and Maturation of Dendritic Cells Stimulated by Recombinant pp65 Protein: An in-vitro Design.
Nikmanesh Y; Karimi MH; Yaghobi R; Marashi SM; Mahmoudi M; Moravej A; Shahmahmoodi S
Iran J Immunol; 2019 Mar; 16(1):11-25. PubMed ID: 30864552
[TBL] [Abstract][Full Text] [Related]
34. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
Yuan J; Latouche JB; Hodges J; Houghton AN; Heller G; Sadelain M; Riviere I; Young JW
J Immunol; 2006 Feb; 176(4):2357-65. PubMed ID: 16455993
[TBL] [Abstract][Full Text] [Related]
35. A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.
Foster AE; Bradstock KF; Sili U; Marangolo M; Rooney CM; Gottlieb DJ
Biol Blood Marrow Transplant; 2004 Nov; 10(11):761-71. PubMed ID: 15505607
[TBL] [Abstract][Full Text] [Related]
36. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
[TBL] [Abstract][Full Text] [Related]
37. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
38. IFN-DC Loaded with Autophagosomes containing Virus Antigen is Highly Efficient in Inducing Virus-Specific Human T Cells.
Fan J; Wu Y; Jiang M; Wang L; Yin D; Zhang Y; Ye W; Yi Y
Int J Med Sci; 2019; 16(5):741-750. PubMed ID: 31217742
[TBL] [Abstract][Full Text] [Related]
39. Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
Renneson J; Salio M; Mazouz N; Goldman M; Marchant A; Cerundolo V
Clin Exp Immunol; 2005 Mar; 139(3):468-75. PubMed ID: 15730392
[TBL] [Abstract][Full Text] [Related]
40. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
